Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Catherine Kegakilwe Koofhethile, Ph.D.

Concepts (71)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Catherine Koofhethile's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Catherine Koofhethile has written about over time.
CD8-Positive T-Lymphocytes, 4 publications between 2010 and 2016, average publication date May 2014. Immunodominant Epitopes, 2 publications between 2014 and 2015, average publication date December 2014. T-Lymphocytes, Cytotoxic, 2 publications between 2014 and 2016, average publication date April 2015. Histocompatibility Antigens Class I, 1 publications between 2016 and 2016, average publication date July 2016. HIV Infections, 12 publications between 2010 and 2024, average publication date March 2019. Virus Activation, 1 publications between 2019 and 2019, average publication date October 2019. Antiretroviral Therapy, Highly Active, 3 publications between 2016 and 2024, average publication date March 2020. Viremia, 2 publications between 2016 and 2024, average publication date June 2020. Viral Load, 6 publications between 2015 and 2024, average publication date August 2020. HIV-1, 8 publications between 2015 and 2024, average publication date October 2020. DNA, Viral, 2 publications between 2019 and 2022, average publication date May 2021. Proviruses, 4 publications between 2019 and 2023, average publication date November 2021. Leukocytes, Mononuclear, 2 publications between 2020 and 2023, average publication date May 2022. CD4-Positive T-Lymphocytes, 3 publications between 2020 and 2023, average publication date July 2022. Mozambique, 1 publications between 2022 and 2022, average publication date December 2022. Botswana, 4 publications between 2020 and 2024, average publication date January 2023. HIV Seropositivity, 2 publications between 2022 and 2023, average publication date May 2023. HIV-2, 1 publications between 2023 and 2023, average publication date November 2023. Heterocyclic Compounds, 3-Ring, 1 publications between 2024 and 2024, average publication date April 2024. Oxazines, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Koofhethile's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.